suvorexant 5 MG Oral Tablet [Belsomra]

RxCUI: 1547575
RxNorm name: suvorexant 5 MG Oral Tablet [Belsomra]
Display name: suvorexant 5 MG Oral Tablet [Belsomra]
Full name: suvorexant 5 MG Oral Tablet [Belsomra]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
BELSOMRA	SUVOREXANT	Merck Sharp & Dohme LLC	e5b72731-1acb-45b7-9c13-290ad12d3951	2025-03-10	Warnings, Adverse reactions	Exact identifier rxcui: 1547575

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e5b72731-1acb-45b7-9c13-290ad12d3951	Belsomra 5 MG Oral Tablet [PSN] · suvorexant 5 MG Oral Tablet [Belsomra] [SBD] · Belsomra 5 MG Oral Tablet [SY]	3	21	These highlights do not include all the information needed to use BELSOMRA safely and effectively. See full prescribing information for BELSOMRA. BELSOMRA ® (suvorexant) tablets, for oral use, C-IV Initial U.S. Approval: 2014	20250310